5 CHAPTER 5 110 20. Kress M, Guthmann C, Averbeck B, Reeh PW. Calcitonin gene-related peptide and prostaglandin E2 but not substance P release induced by antidromic nerve stimulation from rat skin in vitro. Neuroscience. 1999;89(1):303310. 21. Onderwater GLJ, Dool J, Ferrari MD,Terwindt GM. Premonitory symptoms in glyceryl trinitrate triggered migraine attacks: a casecontrol study. Pain. 2020;161(9):2058-2067. 22. Arnold WP, Mittal CK, Katsuki S, Murad F. Nitric oxide activates guanylate cyclase and increases guanosine 3’:5’-cyclic monophosphate levels in various tissue preparations. Proc Natl Acad Sci U S A. 1977;74(8):3203-3207. 23. Taffi R, Vignini A, Lanciotti C, et al. Platelet membrane fluidity and peroxynitrite levels in migraine patients during headache-free periods. Cephalalgia. 2005;25(5):353-358. 24. Bredt DS. Endogenous nitric oxide synthesis: biological functions and pathophysiology. Free Radic Res. 1999;31(6):577-596. 25. Ndengele MM, Cuzzocrea S, Esposito E, et al. Cyclooxygenases 1 and 2 contribute to peroxynitrite-mediated inflammatory pain hypersensitivity. FASEB J. 2008;22(9):31543164. 26. Akerman S, Salvemini D, Romero-Reyes M. Targeting reactive nitroxidative species in preclinical models of migraine. Cephalalgia. 2021;41(11-12):1187-1200. 27. Schubert R, Nelson MT. Protein kinases: tuners of the BKCa channel in smooth muscle. Trends Pharmacol Sci. 2001;22(10):505-512. 28. Murphy ME, Brayden JE. Nitric oxide hyperpolarizes rabbit mesenteric arteries via ATP-sensitive potassium channels. J Physiol. 1995;486 ( Pt 1)(Pt 1):47-58. 29. Miyoshi H, Nakaya Y. Calcitonin gene-related peptide activates the K+ channels of vascular smooth muscle cells via adenylate cyclase. Basic Res Cardiol. 1995;90(4):332-336. 30. Hosokawa S, Endoh T, Shibukawa Y, et al. Calcitonin gene-related peptide- and adrenomedullin-induced facilitation of calcium current by different signal pathways in nucleus tractus solitarius. Brain Res. 2010;1327:47-55. 31. Markovič T, Jakopin Ž, Dolenc MS, MlinaričRaščan I. Structural features of subtypeselective EP receptor modulators. Drug discovery today. 2017;22(1):57-71. 32. Chrissobolis S, Sobey CG. Inwardly rectifying potassium channels in the regulation of vascular tone. Curr Drug Targets. 2003;4(4):281-289. 33. Al-Karagholi MA, Hansen JM, Guo S, Olesen J, Ashina M. Opening of ATP-sensitive potassium channels causes migraine attacks: a new target for the treatment of migraine. Brain. 2019;142(9):2644-2654. 34. Al-Karagholi MA, Ghanizada H, Waldorff Nielsen CA, et al. Opening of BKCa channels causes migraine attacks: a new downstream target for the treatment of migraine. Pain. 2021;162(10):2512-2520. 35. Dekker J, Martherus T, Lopriore E, et al. The Effect of Initial High vs. Low FiO2 on Breathing Effort in Preterm Infants at Birth: A Randomized Controlled Trial. Clinical Trial. Front Pediatr. 2019;7504.: 36. Onderwater GLJ, Wijnen JP, Najac C, et al. Cortical glutamate and gammaaminobutyric acid over the course of a provoked migraine attack, a 7 Tesla magnetic resonance spectroscopy study. Neuroimage Clin. 2021;32:102889. 37. Tassorelli C, Greco R, Armentero MT, et al. A role for brain cyclooxygenase-2 and prostaglandin-E2 in migraine: effects of nitroglycerin. Int Rev Neurobiol. 2007;82:373382. 38. Sarchielli P, Alberti A, Codini M, Floridi A, Gallai V. Nitric oxide metabolites, prostaglandins and trigeminal vasoactive peptides in internal jugular vein blood during spontaneous migraine attacks. Cephalalgia. 2000;20(10):907-918. 39. Nattero G, Allais G, De Lorenzo C, et al. Relevance of prostaglandins in true menstrual migraine. Headache. 1989;29(4):233-238. 40. Vardi J, Flechter S, Alguati A, Regev I, Ayalon D. Prostaglandin--E2 levels in the saliva of common migrainous women. Headache. 1983;23(2):59-61.
RkJQdWJsaXNoZXIy MTk4NDMw